Free Trial
OTCMKTS:ETBI

Eastgate Biotech (ETBI) Stock Price, News & Analysis

Eastgate Biotech logo
$0.0045
0.00 (0.00%)
(As of 10/31/2024 ET)

About Eastgate Biotech Stock (OTCMKTS:ETBI)

Key Stats

Today's Range
$0.0045
$0.0045
50-Day Range
N/A
52-Week Range
$0.0001
$0.01
Volume
N/A
Average Volume
120,278 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. Eastgate Biotech Corp. has collaboration with Biotech Corp. to develop a vaccine against COVID-19. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada.

Receive ETBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eastgate Biotech and its competitors with MarketBeat's FREE daily newsletter.

ETBI Stock News Headlines

Eastgate Biotech Corp. (ETBI)
EVAX Evaxion Biotech A/S
Banking failure dead ahead
If you missed it, my emergency election broadcast is now available - but will be removed soon
Best Biotech Stocks Right Now
Coral Academy Eastgate
Eastgate Nursing & Rehabilitation Center
The Seven Deadly Sins of Biotech Investing
See More Headlines

ETBI Stock Analysis - Frequently Asked Questions

Eastgate Biotech's stock was trading at $0.01 at the start of the year. Since then, ETBI shares have decreased by 55.0% and is now trading at $0.0045.
View the best growth stocks for 2024 here
.

Shares of ETBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eastgate Biotech investors own include Delcath Systems (DCTHD), OPKO Health (OPK), Ovintiv (OVV), Cassava Sciences (SAVA), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM) and CVS Health (CVS).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Trading
Current Symbol
OTCMKTS:ETBI
Previous Symbol
OTCMKTS:ESAQ
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:ETBI) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners